poisar

Stock

uniQure N.V. QURE

$40.17+9.57%

Overview

QURE market data

Price History

QURE price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$3.46
Diluted earnings per share over the trailing twelve months.
Beta
0.90
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$8.73 – $71.50
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $2.5K · P/B 7.41 · P/S 137.81.

Company News

10 captured
uniQure shares are trading higher after the company reported better-than-expected Q2 sales results.Benzinga · Jul 29, 2026, 12:08 PM
uniQure Q2 EPS $(1.22) Misses $(0.82) Estimate, Sales $5.800M Beat $5.467M EstimateBenzinga · Jul 29, 2026, 11:06 AM
8-K filing — uniQure N.V. (QURE)SEC EDGAR · Jul 29, 2026, 11:06 AM
Applied Materials To Rally Around 20%? Here Are 10 Top Analyst Forecasts For MondayBenzinga · Jun 29, 2026, 1:05 PM
What's Going On With Capricor Therapeutics Stock On Friday?Benzinga · Jun 26, 2026, 6:10 PM
Mizuho Maintains Outperform on uniQure, Raises Price Target to $68Benzinga · Jun 25, 2026, 4:20 PM
Backblaze, Infleqtion, Zeta Global And Other Big Stocks Moving Higher On TuesdayBenzinga · Jun 23, 2026, 2:10 PM
uniQure Announces $150M OfferingBenzinga · Jun 22, 2026, 8:05 PM
uniQure's Experimental Drug Shows Early Promise In Difficult-To-Treat EpilepsyBenzinga · Jun 22, 2026, 3:55 PM
Regenxbio Gains Fresh Chance As FDA Reconsiders Gene TherapyBenzinga · Jun 22, 2026, 1:25 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock